Fidelity Advisor Biotechnology Fund Class M (FBTTX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Fidelity Advisor Biotechnology Fund Class M, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Fidelity Advisor Biotechnology Fund Class M (FBTTX) has returned -2.77% so far this year and 42.32% over the past 12 months. Over the last ten years, FBTTX has returned 10.99% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Dec 27, 2000, FBTTX's average daily return is +0.04%, while the average monthly return is +0.83%. At this rate, your investment would double in approximately 7.0 years.

Historically, 60% of months were positive and 40% were negative. The best month was Dec 2023 with a return of +19.5%, while the worst month was Jan 2016 at -26.6%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 6 months.

On a daily basis, FBTTX closed higher 51% of trading days. The best single day was Oct 13, 2008 with a return of +12.6%, while the worst single day was Mar 16, 2020 at -11.7%.

Fidelity Advisor Biotechnology Fund Class M has an annualized alpha of 3.61%, beta of 0.92, and R² of 0.45 versus S&P 500 Index. Calculated based on daily prices since December 28, 2000.

• This fund captured 102.84% of S&P 500 Index gains but only 96.67% of its losses — a favorable profile for investors.
• R² of 0.45 means the benchmark explains less than half of this fund's behavior — treat beta with caution or consider switching to a more representative benchmark.

FBTTX has a high expense ratio of 1.28%, indicating above-average management fees.

FBTTX ranks 82 for risk / return — in the top 82% of mutual funds on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class M (FBTTX) and compare them to a chosen benchmark (S&P 500 Index).

Fidelity Advisor Biotechnology Fund Class M provided a 1.58% dividend yield over the last twelve months, with an annual payout of $0.52 per share.

The table displays the monthly dividend distributions for Fidelity Advisor Biotechnology Fund Class M. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Fidelity Advisor Biotechnology Fund Class M. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Fidelity Advisor Biotechnology Fund Class M was 63.75%, occurring on Jul 10, 2002. Recovery took 2396 trading sessions.

The current Fidelity Advisor Biotechnology Fund Class M drawdown is 7.33%.

The chart below shows the rolling one-month volatility.